Assessment of wall inflammation and fibrosis in Crohn’s disease: value of T1-weighted gadolinium-enhanced MR imaging
- 24 November 2011
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 37 (6) , 933-943
Abstract
MRI is increasingly advocated as a robust method for quantifying disease activity in Crohn’s disease. In particular, T1-weighted gadolinium-enhanced imaging shows considerable promise as a marker of inflammatory activity. However, interpretation of the literature must be made with an understanding of (i) the technical limitations of T1-weighted acquisition protocols and enhancement measurements; (ii) differences in standards of reference for disease activity employed between published studies; and (iii) important underlying macro and micro vascular changes in Crohn’s disease. This review will focus specifically on the value of T1-weighted gadolinium-enhanced imaging in the assessment of wall inflammation and fibrosis.Keywords
This publication has 40 references indexed in Scilit:
- Mapping of T1‐values and Gadolinium‐concentrations in MRI as indicator of disease activity in luminal Crohn's disease: A feasibility studyJournal of Magnetic Resonance Imaging, 2009
- Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s diseaseGut, 2009
- Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive proteinGut, 2006
- Angiogenesis as a Novel Component of Inflammatory Bowel Disease PathogenesisGastroenterology, 2006
- Increased carotid intima–media thickness in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2005
- Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDGastrointestinal Endoscopy, 2004
- Hydro-MRI in Crohn’s DiseaseInvestigative Radiology, 2000
- Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease.Gut, 1993
- High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitisThe Lancet, 1992
- PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTIONThe Lancet, 1989